LIMITED STAGE FOLLICULAR LYMPHOMA: THE ROLE OF RADIATION THERAPY.

Andrea Riccardo Filippi

DOI: 10.4084/mjhid.2016.041

 

PDF

 

HTML

 

e2016041

 

THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.

Francesco Maura, Lucia Farina, Paolo Corradini

DOI: 10.4084/mjhid.2016.045

 

 

PDF

 

HTML

 

e201604

SYSTEMIC FRONT LINE THERAPY OF FOLLICULAR LYMPHOMA: WHEN, TO WHOM AND HOW

Francesca Pavanello, Sara Steffanoni, Michele Ghielmini, Emanuele Zucca

DOI: 10.4084/mjhid.2016.062

 

 

 

PDF

 

HTML

 

e2016062

NOVEL DRUGS IN FOLLICULAR LYMPHOMA

Giuseppe Rossi, Antonella Anastasia

DOI: 10.4084/mjhid.2016.061

 

PDF

HTML

 

e2016061

 

IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?

Giuseppe Gritti, Chiara Pavoni, Alessandro Rambaldi

DOI: 10.4084/mjhid.2017.010

 

 

 

PDF

 

HTML

 

e2017010

 

FOLLICULAR LYMPHOMA: THE MANAGEMENT OF ELDERLY PATIENT

Alessia Castellino, Umberto Vitolo

DOI: 10.4084/mjhid.2017.009 

 

PDF

 

HTML

 

e2017009